Cellphire: Cellphire Therapeutics Names Michael Gaffney as Company's New CEO

(marketscreener.com) ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that Michael Gaffney has joined the company as Chief Executive Officer, effective immediately. Mr. Gaffney...https://www.marketscreener.com/news/latest/Cellphire-Therapeutics-Names-Michael-Gaffney-as-Company-s-New-CEO--33016562/?utm_medium=RSS&utm_content=20210420